A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Bristol-Myers Squibb
City of Hope Medical Center
Pfizer
Hellenic Cooperative Oncology Group
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Tianjin Medical University Cancer Institute and Hospital
Institut de cancérologie Strasbourg Europe
Henan Cancer Hospital
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Fox Chase Cancer Center
Alliance for Clinical Trials in Oncology
Hoffmann-La Roche
Hoffmann-La Roche
GlaxoSmithKline
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Duke University
Roswell Park Cancer Institute
GlaxoSmithKline